Fibrinogen, viscosity and the 10-year incidence of ischaemic heart disease
- PMID: 8960422
- DOI: 10.1093/oxfordjournals.eurheartj.a014797
Fibrinogen, viscosity and the 10-year incidence of ischaemic heart disease
Abstract
Aims: To use the ten year follow-up of the Caerphilly and Speedwell studies to assess the contributions of fibrinogen and viscosity to the prediction of risk of ischaemic heart disease.
Methods and results: Caerphilly and Speedwell are prospective studies based on representative samples of middle-aged males. Ischaemic heart disease morbidity and mortality were defined using hospital notes, repeat electro-cardiographs and death certificates. There were 603 incident events among the 4860 men. Age-adjusted relative odds of ischaemic heart disease increased to 3.3 and 3.4 in the 20% of men with the highest levels of fibrinogen and viscosity, respectively. After standardizing for the major cardiovascular risk factors, these relative odds were 2.2 (95% confidence interval 1.6 to 3.1) for fibrinogen and 2.3 (95% confidence interval 1.7 to 3.2) for viscosity. When fibrinogen and viscosity were entered jointly, both remained significant (P < 0.01) predictors. Incidence of ischaemic heart disease increased with increasing fibrinogen at every level of viscosity, and vice versa. Interactions with lipids were also examined. There was no support for the suggestion that risk is independent of cholesterol level when fibrinogen is low.
Conclusions: Fibrinogen and viscosity are powerful, long term and independent predictors of the risk of ischaemic heart disease.
Comment in
-
Fibrinogen, viscosity and ischaemic heart disease risk.Eur Heart J. 1996 Dec;17(12):1780-1. doi: 10.1093/oxfordjournals.eurheartj.a014789. Eur Heart J. 1996. PMID: 8960414 No abstract available.
Similar articles
-
Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies.Circulation. 1991 Mar;83(3):836-44. doi: 10.1161/01.cir.83.3.836. Circulation. 1991. PMID: 1999035
-
Fibrinogen, viscosity and white blood cell count predict myocardial, but not cerebral infarction: evidence from the Caerphilly and Speedwell cohort.Thromb Haemost. 2002 Mar;87(3):421-5. Thromb Haemost. 2002. PMID: 11916073
-
The relative power of heat-precipitation nephelometric and clottable (Clauss) fibrinogen in the prediction of ischaemic heart disease: the Caerphilly and Speedwell studies.Br J Haematol. 1998 Mar;100(3):582-8. doi: 10.1046/j.1365-2141.1998.00604.x. Br J Haematol. 1998. PMID: 9504645
-
Milk drinking, ischaemic heart disease and ischaemic stroke II. Evidence from cohort studies.Eur J Clin Nutr. 2004 May;58(5):718-24. doi: 10.1038/sj.ejcn.1601869. Eur J Clin Nutr. 2004. PMID: 15116074 Review.
-
Fibrinogen in ischaemic heart disease.Eur Heart J. 1995 Mar;16 Suppl A:31-4; discussion 34-5. doi: 10.1093/eurheartj/16.suppl_a.31. Eur Heart J. 1995. PMID: 7796828 Review.
Cited by
-
Exercise, Cardiovascular Health, and Risk Factors for Atherosclerosis: A Narrative Review on These Complex Relationships and Caveats of Literature.Front Physiol. 2020 Jul 31;11:840. doi: 10.3389/fphys.2020.00840. eCollection 2020. Front Physiol. 2020. PMID: 32848823 Free PMC article. Review.
-
Is fibrinogen plasma level a risk factor for the first 24-hour death of medically treated acute type A aortic dissection patients?Ann Transl Med. 2020 Aug;8(16):1015. doi: 10.21037/atm-20-5466. Ann Transl Med. 2020. PMID: 32953815 Free PMC article.
-
Plasma haemostatic markers, endothelial function and ambulatory blood pressure changes with home versus hospital cardiac rehabilitation: the Birmingham Rehabilitation Uptake Maximisation Study.Heart. 2006 Dec;92(12):1732-8. doi: 10.1136/hrt.2006.092163. Epub 2006 Jun 28. Heart. 2006. PMID: 16807272 Free PMC article. Clinical Trial.
-
Proteome and Peptidome of Vipera berus berus Venom.Molecules. 2016 Oct 19;21(10):1398. doi: 10.3390/molecules21101398. Molecules. 2016. PMID: 27775574 Free PMC article.
-
Carotid intima-media thickness and plasma fibrinogen among subjects with metabolic syndrome: Isfahan cohort study, Iran.ARYA Atheroscler. 2014 Sep;10(5):238-43. ARYA Atheroscler. 2014. PMID: 25477980 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources